{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:51:37Z","timestamp":1776779497130,"version":"3.51.2"},"reference-count":90,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.prp.2020.153098","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T11:06:12Z","timestamp":1593860772000},"page":"153098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Thyroid cancer and thyroid autoimmune disease: A review of molecular aspects and clinical outcomes"],"prefix":"10.1016","volume":"216","author":[{"given":"Nat\u00e1lia Medeiros","family":"Dias Lopes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah Hamada","family":"Mendon\u00e7a Lens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Armani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poliana Camila","family":"Marinello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra Louren\u00e7o","family":"Cecchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2020.153098_bib0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/bmb\/ldr030","article-title":"The epidemiology of thyroid disease","volume":"99","author":"Vanderpump","year":"2011","journal-title":"Br. Med. Bull."},{"issue":"4","key":"10.1016\/j.prp.2020.153098_bib0010","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1210\/js.2018-00427","article-title":"The impact of hashimoto thyroiditis on thyroid nodule cytology and risk of thyroid cancer","volume":"3","author":"Morais","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.prp.2020.153098_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/thy.2016.0100","article-title":"Systematic review of trends in the incidence rates of thyroid cancer","volume":"26","author":"Wiltshire","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.prp.2020.153098_bib0020","unstructured":"A. Bychkov. World Health Organization (WHO) classification. PathologyOutlines.com website. http:\/\/www.pathologyoutlines.com\/topic\/thyroidwho.html\/ (Accessed July 25th, 2019)."},{"key":"10.1016\/j.prp.2020.153098_bib0025","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s12253-019-00580-w","article-title":"Thyroid carcinoma coexisting with Hashimoto\u2019s thyreoiditis: clinicopathological and molecular characteristics clue up pathogenesis","volume":"25","author":"Moln\u00e1r","year":"2019","journal-title":"Pathol. Oncol. Res."},{"issue":"9","key":"10.1016\/j.prp.2020.153098_bib0030","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/ijc.29251","article-title":"Thyroid cancer mortality and incidence: a global overview","volume":"136","author":"La Vecchia","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2020.153098_bib0035","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12020-012-9703-2","article-title":"The incidence and prevalence of thyroid autoimmunity","volume":"42","author":"McLeod","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.prp.2020.153098_bib0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40618-018-0882-4","article-title":"Decreased staging of diferentiated thyroid cancer in patients with chronic lymphocytic thyroiditis","volume":"42","author":"Borowczyk","year":"2019","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.prp.2020.153098_bib0045","doi-asserted-by":"crossref","first-page":"393","DOI":"10.14639\/0392-100X-1709","article-title":"Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients","volume":"37","author":"Liang","year":"2017","journal-title":"Acta otorhinolaryngologica it\u00e1lica"},{"issue":"2","key":"10.1016\/j.prp.2020.153098_bib0050","doi-asserted-by":"crossref","first-page":"128","DOI":"10.31768\/2312-8852.2018.40(2):128-131","article-title":"Differentiated thyroid carcinomas associated with chronic thyroiditis: biological and clinical properties","volume":"40","author":"Myshunina","year":"2018","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.prp.2020.153098_bib0055","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3346\/jkms.2012.27.8.883","article-title":"Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome","volume":"27","author":"Jeong","year":"2012","journal-title":"J. Korean Med. Sci."},{"issue":"3","key":"10.1016\/j.prp.2020.153098_bib0060","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s00405-016-4414-6","article-title":"Thyroid autoimmunity: is really associated with papillary thyroid carcinoma?","volume":"274","author":"Selek","year":"2016","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.prp.2020.153098_bib0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/thy.2009.0450","article-title":"Hashimoto\u2019s thyroiditis is not associated with increased risk of thyroid Cancer in patients with thyroid nodules: a single-center prospective study","volume":"20","author":"Anil","year":"2010","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.prp.2020.153098_bib0070","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hed.23587","article-title":"Thyroid autoimmunity and risk of malignancy in thyroid nodules submitted to fine-needle aspiration cytology","volume":"37","author":"Grani","year":"2014","journal-title":"Head Neck"},{"issue":"9","key":"10.1016\/j.prp.2020.153098_bib0075","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1530\/ERC-17-0085","article-title":"Hashimoto\u2019s thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer","volume":"24","author":"Marotta","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"issue":"10","key":"10.1016\/j.prp.2020.153098_bib0080","first-page":"3011","article-title":"Positive effect of ROR\u03b3t on the prognosis of thyroid papillary carcinoma patients combined with Hashimoto\u2019s thyroiditis","volume":"10","author":"Zeng","year":"2018","journal-title":"Am. J. Transl. Res."},{"issue":"4","key":"10.1016\/j.prp.2020.153098_bib0085","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2265.2009.03537.x","article-title":"Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma","volume":"71","author":"Kim","year":"2009","journal-title":"Clin. Endocrinol."},{"issue":"8","key":"10.1016\/j.prp.2020.153098_bib0090","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00262-015-1705-5","article-title":"Cytokine production in patients with papillary thyroid cancer and associated autoimmune Hashimoto thyroiditis","volume":"64","author":"Zivancevic-Simonovic","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"issue":"4","key":"10.1016\/j.prp.2020.153098_bib0095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nri2742","article-title":"TH17 cells in tumour immunity and immunotherapy","volume":"10","author":"Zou","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.prp.2020.153098_bib0100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nat. Rev. \u2013 Immunol."},{"issue":"9","key":"10.1016\/j.prp.2020.153098_bib0105","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1210\/jc.2005-2337","article-title":"Regulatory T cells in human autoimmune thyroid disease","volume":"91","author":"Marazuela","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.prp.2020.153098_bib0110","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1210\/jc.2009-2564","article-title":"Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid Cancer","volume":"95","author":"French","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2020.153098_bib0115","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40618-017-0794-8","article-title":"Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes","volume":"41","author":"Pilli","year":"2018","journal-title":"J. Endocrinol. Invest."},{"issue":"8","key":"10.1016\/j.prp.2020.153098_bib0120","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1245\/s10434-014-3593-x","article-title":"Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma","volume":"21","author":"Vasileiadis","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.prp.2020.153098_bib0125","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s12020-013-0121-x","article-title":"Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer","volume":"46","author":"Wu","year":"2014","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.prp.2020.153098_bib0130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12020-017-1401-7","article-title":"Thyroid autoimmune antibodies in patients with papillary thyroid carcinoma: a double-edged sword?","volume":"58","author":"Shen","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.prp.2020.153098_bib0135","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1055\/s-0043-120922","article-title":"Papillary thyroid cancer and coexisting autoimmune thyroiditis","volume":"49","author":"Veit","year":"2017","journal-title":"Horm. Metab. Res."},{"issue":"22","key":"10.1016\/j.prp.2020.153098_bib0140","doi-asserted-by":"crossref","first-page":"32318","DOI":"10.18632\/oncotarget.8698","article-title":"Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants","volume":"7","author":"Chowdhury","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2020.153098_bib0145","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12022-018-9540-9","article-title":"Papillary thyroid carcinoma emerging from hashimoto thyroiditis demonstrates increased PD-L1 expression, which persists with metastasis","volume":"29","author":"Lubin","year":"2018","journal-title":"Endocr. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2020.153098_bib0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.molmed.2014.10.009","article-title":"Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway","volume":"21","author":"Ohaegbulam","year":"2015","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.prp.2020.153098_bib0155","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/ERC-16-0421","article-title":"Comprehensive screening for PD-L1 expression in thyroid cancer","volume":"24","author":"Ahn","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2020.153098_bib0160","first-page":"120","article-title":"8-hydroxy-2\u2019 -deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis","volume":"27","author":"Valavanidis","year":"2009","journal-title":"J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev."},{"key":"10.1016\/j.prp.2020.153098_bib0165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.advms.2016.06.003","article-title":"A comparative study of nuclear 8-hydroxyguanosine expression in autoimmune thyroid diseases and papillary thyroid carcinoma and its relationship with p53, Bcl-2 and Ki-67 cancer related proteins","volume":"62","author":"Mseddi","year":"2017","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.prp.2020.153098_bib0170","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cytogfr.2008.08.001","article-title":"Osteopontin: role in immune regulation and stress responses","volume":"19","author":"Wang","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.prp.2020.153098_bib0175","first-page":"4060","article-title":"Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer","volume":"7","author":"Fedarko","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.prp.2020.153098_bib0180","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1210\/jc.2005-0271","article-title":"Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness","volume":"90","author":"Guarino","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2020.153098_bib0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4174\/jkss.2013.84.1.9","article-title":"Osteopontin expression in papillary thyroid carcinoma and its relationship with the BRAF mutation and tumor characteristics","volume":"84","author":"Kang","year":"2013","journal-title":"J. Korean Surg. Soc."},{"issue":"6","key":"10.1016\/j.prp.2020.153098_bib0190","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.7314\/APJCP.2015.16.6.2447","article-title":"Osteopontin levels in patients with papillary thyroid cancer according to the presence of Hashimoto\u2019s thyroiditis","volume":"16","author":"Park","year":"2015","journal-title":"Asian Pacific J. Cancer Prev."},{"issue":"9","key":"10.1016\/j.prp.2020.153098_bib0195","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/sj.bjc.6605624","article-title":"Cancer risk in patients hospitalised for Graves\u2019 disease: a population-based cohort study in Sweden","volume":"102","author":"Shu","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2020.153098_bib0200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2741\/4708","article-title":"Graves\u2019 disease in clinical perspective","volume":"24","author":"Ehlers","year":"2019","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.prp.2020.153098_bib0205","article-title":"Chemokines in hyperthyroidism","volume":"16","author":"Ferrari","year":"2019","journal-title":"J. Clin. Transl. Endocrinol."},{"issue":"1","key":"10.1016\/j.prp.2020.153098_bib0210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12022-014-9343-6","article-title":"Thyroid carcinoma in patients with Graves\u2019 disease: an institutional experience","volume":"26","author":"Wei","year":"2015","journal-title":"Endocr. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2020.153098_bib0215","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000320028","article-title":"Pediatric Graves\u2019 disease: controversies in management","volume":"74","author":"Rivkees","year":"2010","journal-title":"Horm. Res. Paediatr."},{"issue":"8","key":"10.1016\/j.prp.2020.153098_bib0220","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1210\/jc.2018-00026","article-title":"Disease burden and outcome in children and young adults with concurrent graves disease and differentiated thyroid carcinoma","volume":"103","author":"MacFarland","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2020.153098_bib0225","first-page":"129","article-title":"Cyclooxygenase and prostanoids - biological implications","volume":"60","author":"Burdan","year":"2006","journal-title":"Postepy. Hig. Med. Dosw. (Online)"},{"key":"10.1016\/j.prp.2020.153098_bib0230","first-page":"1306","article-title":"Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors","volume":"60","author":"Masferrer","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2020.153098_bib0235","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1365-2559.2003.01624.x","article-title":"Cyclooxygenase-2 expression in thyroid neoplasms","volume":"42","author":"Ito","year":"2003","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.prp.2020.153098_bib0240","first-page":"1","article-title":"Assessment of cyclooxygenase-1 and 2 gene expression levels in chronic autoimmune thyroiditis, papillary thyroid carcinoma and nontoxic nodular goitre","volume":"7","author":"Krawczyk-Rusiecka","year":"2014","journal-title":"Thyroid Res."},{"issue":"5","key":"10.1016\/j.prp.2020.153098_bib0245","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3349\/ymj.2015.56.5.1338","article-title":"Focal lymphocytic thyroiditis nodules share the features of papillary thyroid cancer on ultrasound","volume":"56","author":"Hwang","year":"2015","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.prp.2020.153098_bib0250","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/modpathol.3880312","article-title":"Immunohistochemical diagnosis of papillary thyroid carcinoma","volume":"14","author":"Cheung","year":"2001","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2020.153098_bib0255","first-page":"295","article-title":"High-molecular-weight cytokeratin 19 in the diagnosis of thyroid tumours","volume":"7","author":"Raphael","year":"1994","journal-title":"Mod. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2020.153098_bib0260","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1159\/000325595","article-title":"Expression of cytokeratin 19 and protein p63 in fine needle aspiration biopsy of papillary thyroid carcinoma","volume":"52","author":"Bonzanini","year":"2008","journal-title":"Acta Cytol."},{"issue":"3","key":"10.1016\/j.prp.2020.153098_bib0265","first-page":"250","article-title":"Hashimoto\u2019s thyroiditis and papillary thyroid carcinoma. Are cytokeratin 19 and P63 proteins of any diagnostic value?","volume":"19","author":"Divani","year":"2016","journal-title":"Hell. J. Nucl. Med."},{"key":"10.1016\/j.prp.2020.153098_bib0270","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1600-0463.2007.apm_775.xml.x","article-title":"MicroRNAs and cancer","volume":"115","author":"Cowland","year":"2007","journal-title":"APMIS"},{"key":"10.1016\/j.prp.2020.153098_bib0275","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/jclinpath-2016-203739","article-title":"Intermediate microRNA expression profile in Graves\u2019 disease falls between that of normal thyroid tissue and papillary thyroid carcinoma","volume":"70","author":"Pohl","year":"2017","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2020.153098_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/809382","article-title":"Prognosis of multifocal papillary thyroid carcinoma","volume":"2013","author":"Kuo","year":"2013","journal-title":"Int. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.prp.2020.153098_bib0285","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/0194599815581831","article-title":"High TPOab levels (&1300 IU\/ml) indicate multifocal PTC in Hashimoto\u2019s thyroiditis patients and support total thyroidectomy","volume":"153","author":"Dong","year":"2015","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.prp.2020.153098_bib0290","series-title":"Part II Laboratory Assessment of Thyroid Function","first-page":"360","article-title":"Thyroid-directed antibodies","author":"Marcocci","year":"2005"},{"key":"10.1016\/j.prp.2020.153098_bib0295","series-title":"Characterization of Thyroglobulin Epitopes in Patients with Autoimmune and Non-autoimmune","author":"Latrofa","year":"2008"},{"key":"10.1016\/j.prp.2020.153098_bib0300","unstructured":"Thyroid Diseases Using Recombinant Human Monoclonal Thyroglobulin Autoantibodies. J. Clin. Endocrinol. Metab. 93(2):591\u2013596."},{"key":"10.1016\/j.prp.2020.153098_bib0305","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00428-015-1893-6","article-title":"A small subgroup of Hashimoto\u2019s thyroiditis is associated with IgG4-related disease","volume":"468","author":"Jokisch","year":"2016","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2020.153098_bib0310","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2147\/TCRM.S99985","article-title":"IgG4-related disease: current challenges and future prospects","volume":"12","author":"Lang","year":"2016","journal-title":"Ther. Clin. Risk Manag."},{"issue":"6","key":"10.1016\/j.prp.2020.153098_bib0315","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/ans.12725","article-title":"Warthin-like variant of papillary thyroid carcinoma: single institution experience","volume":"86","author":"Jun","year":"2016","journal-title":"ANZ J. Surg."},{"issue":"2","key":"10.1016\/j.prp.2020.153098_bib0320","first-page":"175","article-title":"Warthin-like papillary thyroid carcinoma with immunoglobulin G4-positive plasma cells possibly related to Hashimoto\u2019s thyroiditis","volume":"65","author":"Hirokawa","year":"2017","journal-title":"Jpn. Endocr. Soc."},{"key":"10.1016\/j.prp.2020.153098_bib0325","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1542\/peds.2013-3926","article-title":"Cancer incidence rates and trends among children and adolescents in the United States, 2001\u20132009","volume":"134","author":"Siegel","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.prp.2020.153098_bib0330","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.21873\/anticanres.11479","article-title":"Thyroid cancer in the pediatric age in Sicily: influence of the volcanic environment","volume":"37","author":"Russo","year":"2017","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.prp.2020.153098_bib0335","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13052-018-0455-3","article-title":"Differentiated thyroid carcinoma presentation may be more aggressive in children and adolescents than in young adults","volume":"44","author":"Zirilli","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.prp.2020.153098_bib0340","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1089\/thy.2015.0275","article-title":"Inaugural management guidelines for children with thyroid nodules and differentiated thyroid cancer: children are not small adults","volume":"25","author":"LaFranchi","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.prp.2020.153098_bib0345","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1089\/thy.2013.0297","article-title":"Treatment approach, surveillance, and outcome of well-differentiated thyroid cancer in childhood and adolescence","volume":"24","author":"Markovina","year":"2014","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.prp.2020.153098_bib0350","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bjorl.2017.08.012","article-title":"Hashimoto\u2019s thyroiditis-an independent risk factor for papillary carcinoma","volume":"84","author":"Uhliarova","year":"2018","journal-title":"Braz. J. Otorhinolaryngol."},{"issue":"1","key":"10.1016\/j.prp.2020.153098_bib0355","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.tem.2014.09.001","article-title":"Hashimoto\u2019s thyroiditis and papillary thyroid cancer: are they immunologically linked?","volume":"25","author":"Ehlers","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.prp.2020.153098_bib0360","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1089\/thy.2013.0588","article-title":"Hashimoto\u2019s thyroiditis pathology and risk for thyroid cancer","volume":"24","author":"Paparodis","year":"2014","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.prp.2020.153098_bib0365","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3803\/EnM.2018.33.2.175","article-title":"Genome-wide association studies of autoimmune thyroid diseases, thyroid function, and thyroid cancer","volume":"33","author":"Hwangbo","year":"2018","journal-title":"Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.prp.2020.153098_bib0370","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1210\/jc.2012-2843","article-title":"Increased mortality in patients with differentiated thyroid cancer associated with Graves\u2019 disease","volume":"98","author":"Pellegriti","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.prp.2020.153098_bib0375","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/00365513.2015.1057895","article-title":"IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent\/recurrent disease in papillary thyroid carcinoma with\/without Hashimoto\u2019s thyroiditis","volume":"75","author":"Stanciu","year":"2015","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"4","key":"10.1016\/j.prp.2020.153098_bib0380","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1210\/jc.2015-3783","article-title":"Clinical relationship between IgG4-positive Hashimoto\u2019s thyroiditis and papillary thyroid carcinoma","volume":"101","author":"Yu","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2020.153098_bib0385","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1089\/thy.2013.0126","article-title":"On the association between Hashimoto\u2019 s thyroiditis and papillary thyroid carcinoma: looking 100 years back and, hopefully, fewer years ahead to sort out this association","volume":"23","author":"Benvenga","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.prp.2020.153098_bib0390","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000468928","article-title":"Thyroid autoimmunity and thyroid cancer: review focused on cytological studies","volume":"6","author":"Boi","year":"2017","journal-title":"Eur. Thyroid J."},{"issue":"2","key":"10.1016\/j.prp.2020.153098_bib0395","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archsurg.1955.01270080137023","article-title":"Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland","volume":"70","author":"Dailey","year":"1955","journal-title":"AMA Arch. Surg."},{"key":"10.1016\/j.prp.2020.153098_bib0400","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.beem.2013.07.003","article-title":"Thyroglobulin antibody (TgAb) methods -strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer","volume":"27","author":"Spencer","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2020.153098_bib0405","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0889-8529(18)30023-9","article-title":"Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls","volume":"24","author":"Spencer","year":"1995","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"5","key":"10.1016\/j.prp.2020.153098_bib0410","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.amjsurg.2015.12.030","article-title":"Thyroglobulin antibodies as a potential predictive marker of papillary thyroid carcinoma in patients with indeterminate cytology","volume":"212","author":"Karatzas","year":"2016","journal-title":"Am. J. Surg."},{"issue":"1","key":"10.1016\/j.prp.2020.153098_bib0415","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1210\/jc.2014-2725","article-title":"Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer","volume":"100","author":"Lupoli","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2020.153098_bib0420","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2188\/jea.JE20100128","article-title":"High-sensitivity C-reactive protein and cancer","volume":"21","author":"Lee","year":"2011","journal-title":"J. Epidemiol."},{"issue":"6","key":"10.1016\/j.prp.2020.153098_bib0425","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/cam4.330","article-title":"Interleukin-4 receptor alpha overexpression in human bladder cancer correlates with the pathological grade and stage of the disease","volume":"3","author":"Joshi","year":"2014","journal-title":"Cancer Med."},{"issue":"16","key":"10.1016\/j.prp.2020.153098_bib0430","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1158\/0008-5472.CAN-14-0093","article-title":"IL4 receptor ILR4alpha regulates metastatic colonization by mammary tumors through multiple signaling pathways","volume":"74","author":"Venmar","year":"2014","journal-title":"Cancer Res."},{"issue":"111","key":"10.1016\/j.prp.2020.153098_bib0435","first-page":"273","article-title":"Identification, characterization, and targeting of IL-4 receptor by IL-4-Pseudomonas exotoxin in mouse models of anaplastic thyroid cancer","volume":"20","author":"Joshi","year":"2015","journal-title":"Discov. Med."},{"issue":"2","key":"10.1016\/j.prp.2020.153098_bib0440","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00262-016-1924-4","article-title":"Interleukin 10 expression is related to aggressiveness and poor prognosis of patients with thyroid cancer","volume":"66","author":"Cunha","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"issue":"8","key":"10.1016\/j.prp.2020.153098_bib0445","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/modpathol.2012.68","article-title":"Distinct histopathological features of Hashimoto\u2019s thyroiditis with respect to IgG4-related disease","volume":"25","author":"Li","year":"2012","journal-title":"Mod. Pathol."},{"issue":"12","key":"10.1016\/j.prp.2020.153098_bib0450","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/apm.12297","article-title":"The role of IgG4 plasma cells in the association of Hashimoto\u2019s thyroiditis with papillary carcinoma","volume":"122","author":"Tasli","year":"2014","journal-title":"APMIS"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033820319531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033820319531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:45:42Z","timestamp":1759733142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033820319531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":90,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0344033820319531"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2020.153098","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid cancer and thyroid autoimmune disease: A review of molecular aspects and clinical outcomes","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2020.153098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153098"}}